Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Karo Pharma SA (KARO)

Stockholm
Currency in SEK
Disclaimer
60.70
0.00(0.00%)
Closed
Fair Value
Unlock Value
Day's Range
60.4061.00
52 wk Range
49.2562.05
Prev. Close
60.5
Open
60.4
Day's Range
60.4-61
52 wk Range
49.25-62.05
Volume
0
Average Volume (3m)
242,431
1-Year Change
0%
Shares Outstanding
273,254,604
Fair Value
Unlock
Dividends Payment Streak
Unlock
Technical
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Daily
Weekly
Monthly
More
How do you feel today about KARO?
Vote to see community's results!
or

Karo Pharma Company Profile

Karo Healthcare AB, a healthcare company, develops and markets over-the-counter products and prescription drugs for pharmacies, digital distribution channels, and retail sector in Sweden, Norway, Denmark, Finland, France, Germany, Italy, the United Kingdom, rest of Europe, the United States, and internationally. It offers skin health products under the E45, Remescar, Locobase, Decubal, and indy beauty brand names; intimate health products under the Pevaryl, Multi Gyn, Asan, and Selexid brands; digestive products under the Scheriproct and Hemoproct brand names; and foot health products under the Pevaryl, Nailner, CCS, and wortie brands. The company also provides wellness products under the nutravita, Alpha Foods, Flux, Allévo, and Lactocare brand names; pain, cough, and cold products under the Paracet, Ibux, Mollipect, and Viruseptin brands; and specialty products under the Burinex, Centyl, Kaleorid, and Lithionit brand names. It sells its products in Europe and the Nordic region markets through direct sales organizations and a network of distributors, as well as online. Karo Healthcare AB was formerly known as Karo Pharma AB (publ). The company was incorporated in 1987 and is headquartered in Stockholm, Sweden. Karo Healthcare AB operates as a subsidiary of Karo Intressenter AB.

Employees
369
Market
Sweden
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.